MOLOGEN AG / Key word(s): Capital Increase
13.01.2011 19:53
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
The Board of Directors of Mologen AG (ISIN: DE 000 663 720 0) decided today
with the approval of the Supervisory Board to use the existing authorized
capital 2010 in accordance with Para. 4 section 3 of the Articles of
Association and to carry out a capital increase with shareholder
subscription rights. By issuing up to 1,245,927 new shares, the current
share capital of 11,213,348 EUR is set to increase to 12,459,275 EUR. The
inflow of funds from the capital increase serves to strengthen the capital
stock basis. It is to be used for the financing of further company growth
by developing the product pipeline as well as for the financing of ongoing
business operations which are necessary for this. The new shares shall
carry dividend rights as of January 1, 2010.
Within the scope of the rights issue, an indirect rights issue is being
granted to the shareholders for the up to 1,245,927 new shares. The
shareholders of the company are invited, through the publication of the
rights issue in the electronic Federal Gazette (elektronischer
Bundesanzeiger) on January 14, 2011, to exercise their subscription rights
in the period from January 17 through 31 (inclusive) to avoid exclusion.
The purchase relationship is 9:1, i.e. every nine existing Mologen shares
authorize the purchase of a new share at the purchase price. Each
shareholder can issue an additional purchase order beyond the legal
subscription right - without guarantee of allocation. The oversubscription
should be carried out within the same time period as the regular
subscription. The shareholders cannot purchase any new shares for
fractional amounts which result computationally from the individual share
status of the purchase ratio of 9:1. Only the purchase of one new share or
an integer multiple of this is possible. The quirin bank AG, Berlin,
functions as a subscription agent and is also authorized for the signing
and takeover of the new shares.
The purchase price is only determined during the subscription period, no
later however than January 26, 2011 at 12:00 CET, under consideration of
the current market situation of the company. The purchase price is
determined between (each inclusive) the weighted average price of the
company's shares in the electronic trading system XETRA of the Frankfurt
Stock Exchange from the beginning of the subscription period to the
determination of the purchase price, and the current stock price of the
company at the time of the determination of the purchase price. For the
determination of the final purchase price, the company reserves the right
to carry out an additional discount of up to 15% to the initially
determined price. The purchase price is at least 1 EUR per share,
corresponding to the lowest face value.
In the event that new shares are available due to non-exercised purchase
rights and after oversubscription, these unpurchased new shares will be
sold to interested investors at the purchase price through an international
private placement in Germany and other countries. The private placement
begins on February 1, 2011 and is expected to end on February 2, 2011 at
16:00 CET (extension or curtailment is possible).
Note:
This ad-hoc notification represents neither a request nor an offer to
submit an offer for the purchase of securities. This is particularly the
case in the USA and other countries or jurisdictions where an offer would
be unauthorized for the submission of a bid for the purchase or sale
without previous registration or authorization. The respective relevant
legal provisions concerning securities for these countries and
jurisdictions apply.
This ad-hoc notification represents neither an offer for the sale of shares
without a par value attributed to the owner, nor a request to submit an
offer for the purchase of shares without a par value, but rather serves
solely to provide information.
For further information:
MOLOGEN AG
Fabeckstrasse 30
D-14195 Berlin, Germany
Tel: +49 (0) 30 - 84 17 88 - 0
Investor Relations
Joerg PetraÃ
investor@mologen.com
Tel: +49 (0) 30 - 84 17 88 - 13
Press Contact
Prof. Peter W. Huebner
huebner@mologen.com
Tel: +49 (0) 30 - 84 17 88 - 38
External Investor Relations
Kirchhoff Consult AG
Jens Hecht
jens.hecht@kirchhoff.de
Tel: +49 (0) 40 - 60 91 86 - 82
13.01.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: MOLOGEN AG
FabeckstraÃe 30
14195 Berlin
Deutschland
Phone: 030 / 841788-0
Fax: 030 / 841788-50
E-mail: info@mologen.com
Internet: www.mologen.com
ISIN: DE0006637200
WKN: 663720
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: MOLOGEN AG announces its decision on a capital increase from authorized capital
| Source: EQS Group AG